More less-expensive, generic drugs would hit the market under a bipartisan bill being considered by a Senate panel Thursday.

The bill, known as the Creates Act, has been stalled for months as it faced opposition by the pharmaceutical industry. The bill has been placed on the Judiciary Committee calendar for Thursday, which would set it up for a vote next week.